Seattle biotech firm Kineta raises $1.6 million to boost its battle against disease
Kineta, a Seattle-based biotech startup, has raised an investment round worth almost $1.6 million from existing investors in the company. The investment will be used to fund continued development of the drugs that the company is working on. “This new raise [...]